Tongji Xie

National Cancer Center

H指数:13

被引数:532

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case report of neoadjuvant treatment with sugemalimab combined with platinum-based doublet chemotherapy in stage IIIB lung squamous cell carcinoma and research in potential biomarkers

III期B期肺鳞状细胞癌患者接受舒格利单抗联合铂类双药化疗新辅助治疗的病例报告及潜在生物标志物研究

Heliyon

IF3.6

2026-09-220

OAAI

Mechanisms and therapeutic targets in distant metastasis of lung adenocarcinoma

肺癌腺癌远处转移的机制和 therapeutic targets

Signal Transduction and Targeted Therapy

IF52.7

2026-07-240

Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma

肺癌EGFR-TKI第三代耐药后免疫治疗联合化疗的生物标志物探索

BMC Cancer

IF3.4

2026-04-140

OAAI

Digital Spatial Profiling Uncovers Transcriptomic Features of Distinct Plasma Cell-like Phenotypes in Diffuse Large B-cell Lymphoma

数字空间分析揭示了弥漫性大B细胞淋巴瘤中不同浆细胞样表型的转录组特征

Blood Advances

IF7.1

2026-03-300

OAAI

A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma

基于队列的多组学分析鉴定出eIF5B/PD-L1/CD44复合物的核转位是克服ARID1A缺失型肺腺癌奥希替尼耐药的靶点

hematology oncology

IF13.5

2025-01-071

Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma

空间分析显示CXCL5和SLC6A14是肝内胆管癌微血管侵犯的标志

HEPATOLOGY COMMUNICATIONS

IF4.6

2025-01-010

OAAI

Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study

基于ORIENT-3研究数据的人工神经网络系统，用于预测 sintilimab 在鳞状非小细胞肺癌中的反应。

CANCER IMMUNOLOGY IMMUNOTHERAPY

IF5.1

2024-12-210

Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma

空间分析显示CXCL5和SLC6A14是肝内胆管癌微血管浸润的标志物。

ANNALS OF ONCOLOGY

IF65.4

2024-12-011

PRE

DKK1+tumor cells inhibited the infiltration of CCL19+fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma

CELL DEATH & DISEASE

IF9.6

2024-11-070

OAAI

The co-location of MARCO plus tumor-associated macrophages and CTSE plus tumor cells determined the poor prognosis in intrahepatic cholangiocarcinoma

HEPATOLOGY

IF15.8

2024-10-290

PRE

Spatial analyses revealed S100P+TFF1+tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer

空间分析显示S100P TFF1肿瘤细胞通过空气空间样本传播与非小细胞肺癌不良治疗反应相关

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-10-091

OAAI

Association of genomic landscape and plasma protein dynamic changes with clinical outcome in patients with R/M HNSCC treated with pembrolizumab with nab-paclitaxel and platinum

基因组景观和血浆蛋白动态变化与接受pembrolizumab联合nab-paclitaxel和铂类药物治疗的R/M HNSCC患者的临床结局的相关性

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Multi-omics analysis of tislelizumab plus nab-paclitaxel and cisplatin as neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A prospective single-arm phase II trial

局部晚期喉咽鳞状细胞癌的新辅助免疫化疗的多组学分析：替雷利珠单抗联合 Nab-紫杉醇和顺铂的 prospective single-arm phase II trial

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

The co-location of CD14+APOE+ cells and MMP7+tumour cells contributed to worse immunotherapy response in non-small cell lung cancer

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-08-260

OAAI

Mutational variant allele frequency profile as a biomarker of response to immune checkpoint blockade in non-small cell lung Cancer

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-06-180

OAAI

Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma

单细胞和空间转录组学揭示高糖酵解b细胞和肿瘤相关巨噬细胞簇与弥漫性大b细胞淋巴瘤的不良预后和耗尽的免疫微环境相关

BIOMARKER RESEARCH

IF11.5

2024-06-053

OAAI

The co-location of MARCO plus tumor-associated macrophages and CTSE plus tumor cells determined the poor prognosis in intrahepatic cholangiocarcinoma

ANNALS OF ONCOLOGY

IF65.4

2024-06-010

PRE

High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer

MOLECULAR & CELLULAR PROTEOMICS

IF5.5

2024-05-012

OAAI

Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma

NPJ PRECISION ONCOLOGY

IF8

2024-03-237

OAAI

Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray

CANCER

IF5.1

2023-12-221

PRE

Tongji Xie

个人简介

教育背景

工作经历

荣誉奖项

研究方向